Viewing Study NCT04210258


Ignite Creation Date: 2025-12-25 @ 12:24 AM
Ignite Modification Date: 2026-02-01 @ 7:25 PM
Study NCT ID: NCT04210258
Status: COMPLETED
Last Update Posted: 2020-01-02
First Post: 2019-12-17
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Post-Market Clinical Follow-up Performance and Safety Study of Etermis 3 and 4 in the Face
Sponsor: Merz Pharmaceuticals GmbH
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module